D. E. Shaw & Co., Inc.
- SEC CIK
- 0001009207
- Latest filing
- Aug 14, 2026
MD holding history
Pediatrix Medical Group, Inc. in every 13F filed by D. E. Shaw & Co., Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
MD overviewAll 13F holders of MDFull Q2 2026 holdings
- Shares (Q2 2026)
- 1,613,100
- Value
- $40.9M
- % of portfolio
- <0.1%
- Quarters held
- 22
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 1,613,100 | $40.9M | <0.1% | −95,333−5.6% | Reduced | Holders |
| Q1 2026 | 1,708,433 | $36.5M | <0.1% | −143,786−7.8% | Reduced | Holders |
| Q4 2025 | 1,852,219 | $39.6M | <0.1% | −169,118−8.4% | Reduced | Holders |
| Q3 2025 | 2,021,337 | $33.9M | <0.1% | +443,575+28.1% | Added | Holders |
| Q2 2025 | 1,577,762 | $22.6M | <0.1% | −294,415−15.7% | Reduced | Holders |
| Q1 2025 | 1,872,177 | $27.1M | <0.1% | −271,319−12.7% | Reduced | Holders |
| Q4 2024 | 2,143,496 | $28.1M | <0.1% | −182,007−7.8% | Reduced | Holders |
| Q3 2024 | 2,325,503 | $27.0M | <0.1% | −138,357−5.6% | Reduced | Holders |
| Q2 2024 | 2,463,860 | $18.6M | <0.1% | +318,373+14.8% | Added | Holders |
| Q1 2024 | 2,145,487 | $21.5M | <0.1% | −94,860−4.2% | Reduced | Holders |
| Q4 2023 | 2,240,347 | $20.8M | <0.1% | +503,823+29.0% | Added | Holders |
| Q3 2023 | 1,736,524 | $22.1M | <0.1% | +7,375+0.4% | Added | Holders |
| Q2 2023 | 1,729,149 | $24.6M | <0.1% | +307,931+21.7% | Added | Holders |
| Q1 2023 | 1,421,218 | $21.2M | <0.1% | +417,317+41.6% | Added | Holders |
| Q4 2022 | 1,003,901 | $14.9M | <0.1% | −3,447−0.3% | Reduced | Holders |
| Q3 2022 | 1,007,348 | $16.6M | <0.1% | +90,053+9.8% | Added | Holders |
| Q2 2022 | 917,295 | $19.3M | <0.1% | +53,344+6.2% | Added | Holders |
| Q1 2022 | 863,951 | $20.3M | <0.1% | +218,888+33.9% | Added | Holders |
| Q4 2021 | 645,063 | $17.6M | <0.1% | +9,281+1.5% | Added | Holders |
| Q3 2021 | 635,782 | $18.1M | <0.1% | −57,435−8.3% | Reduced | Holders |
| Q2 2021 | 693,217 | $20.9M | <0.1% | +167,934+32.0% | Added | Holders |
| Q1 2021 | 525,283 | $13.4M | <0.1% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.